In vivo disposition of Andrographolide was studied in rats. It showed high elimination and moderate bioavailability. 34/39 metabolites were sulfated, making sulfation its main pathway. A novel MS/MS workflow identified 4 sulfation sites.
Sun et al. (Thu,) studied this question.